Latest Payments News

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Asset Vision Co Limited reported a 27% increase in revenue to $3.06 million for the half-year ended December 2025, yet recorded a net loss of $54,052 due to deliberate investments in growth and product development.

BHP Group Limited has announced a fully franked ordinary dividend of USD 0.73 per share for the half-year ending December 2025, with multiple currency payment options and a Dividend Reinvestment Plan available.

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.

Deterra Royalties Limited has announced a fully franked ordinary dividend of AUD 0.124 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a no-discount option to reinvest.

Olympio Metals has intersected multiple visible gold occurrences in its latest diamond drilling at the Paquin prospect within the Bousquet Gold Project, reinforcing the site’s promising potential ahead of assay results expected in March 2026.

SRG Global Limited posted a robust half-year result for December 2025, driven by strong segment growth and the acquisition of Total AMS Pty Ltd. The company also raised its interim dividend, signalling confidence in its outlook.

Macmahon Holdings has reported a robust first half of FY26, delivering double-digit growth in revenue and earnings alongside a significant dividend increase and reaffirmed full-year guidance.

HealthCo Healthcare and Wellness REIT posted a $26.8 million net loss for the half-year ended December 2025, driven by asset sales and fair value declines. The REIT suspended distributions and reduced its property portfolio as it navigates tenant risks and debt refinancing.

Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.

H&G High Conviction Limited has significantly reduced its half-year loss following asset divestment and is actively exploring strategic alternatives to enhance shareholder value amid looming ASX re-compliance requirements.

Contact Energy Limited has reported a striking 43.9% increase in net profit for the half-year ending December 2025, even as revenue fell by 5.3%. The company’s acquisition of Manawa Energy Limited has boosted its net tangible assets, underpinning a healthy interim dividend.